欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0921/001
药品名称
Glucose-Na-K Baxter
活性成分
glucose 50.0 g
magnesium chloride hexahydrate 300.0 mg
potassium chloride 1.5 g
sodium acetate 3.13 g
sodium chloride 1.0 g
剂型
Solution for infusion
上市许可持有人
Baxter Medical AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Denmark (DK)
France (FR)
Netherlands (NL)
Portugal (PT)
Cyprus (CY)
Stabilyte 50mg/ml Solution for Infusion
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Finland (FI)
Bulgaria (BG)
Stabilyte
Malta (MT)
Slovenia (SI)
Romania (RO)
GNAK 50 mg/ml soluție perfuzabilă
Poland (PL)
Spain (ES)
Italy (IT)
Czechia (CZ)
Stabilyte 50 mg/ml Solution for Infusion
Slovakia (SK)
Croatia (HR)
Greece (GR)
Germany (DE)
Maintelyte 50 mg/ml Infusionslösung
许可日期
2009/09/01
最近更新日期
2024/03/19
药物ATC编码
B05BB02 electrolytes with carbohydrates
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PAR
|
SE/H/0921/001_PAR
Date of last change:2015/09/04
Final PL
|
SE/H/0921/001_Final PL
Date of last change:2014/01/15
Final SPC
|
SE/H/0921/001_Final SPC
Date of last change:2014/01/15
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase